TERF2 and age-related macular degeneration: Additionally, no statistically significantly results were found analysing TERF2 serum levels between early AMD vs. control group, and exudative AMD vs. control group (median (IQR): 4.476 (2.200) ng/mL vs. 3.743 (4.235) ng/mL, p = 0.160 (Figure 6); 3.911 (2.462) ng/mL vs. 3.743 (4.235) ng/mL, p = 0.829 (Figure 7), respectively).